William Gray
MD, FACC, MSCAI
System Chief/President
Main Line Health/Lankenau Heart Institute

William A. Gray, M.D. FACC FSCAI
System Chief, Division of Cardiovascular Diseases of Main Line Health
President, Lankenau Heart Institute

William A. Gray, M.D., is an interventional cardiologist, board certified in internal medicine, interventional cardiology, vascular and endovascular medicine. Dr. Gray was at the Center for Interventional Vascular Therapy as Director, Endovascular Intervention at New York Columbia-Presbyterian Hospital.

Prior to joining Columbia University Dr. Gray was Director of the Endovascular Care at Swedish Medical Center from 1999-2005. Before Seattle, Dr. Gray practiced at Southwest Cardiology where he directed research, served as vice-chair of the Cardiology division at Presbyterian Hospital in Albuquerque, N.M., and was a founding member of the Heart Hospital of New Mexico.

Dr. Gray specializes in cardiac/structural and peripheral arterial disease diagnosis and treatment as well as non-surgical modalities for stroke prevention, research into preventing the reoccurrence of disease following successful angioplasty or stenting.

Dr. Gray has been principal investigator for numerous clinical trials, and is routinely asked to speak at national and international conferences. He has also been a consultant and device/procedure proctor for numerous medical corporations, and has been a journal reviewer for the American Medical Association.

Dr. Gray holds a bachelor’s degree in Chemistry from Dickinson College in Carlisle, PA and graduated from Temple University’s School of Medicine in Philadelphia. Dr. Gray’s postgraduate training included an internship, residency, and Chief Residency in Internal Medicine at Brown University/Rhode Island Hospital in Providence, R.I., where he also completed a clinical/research/ interventional fellowship in Cardiology.

Sessions

Register

Femoral-Popliteal Arterial Disease: Data and Treatment Approach

Monday, February 09, 2026
10:20 AM - 10:30 AM

Case-Based Roundtable: Femoral-Popliteal Arterial Disease

Monday, February 09, 2026
10:30 AM - 10:50 AM

Focused Symposium: Carotid Stenting Today: Starting from Scratch

Monday, February 09, 2026
1:30 PM - 3:45 PM

The Changing Landscape of Patient Selection for CAS

Monday, February 09, 2026
1:46 PM - 1:58 PM

Panel Discussion: How Do I Start a Carotid Stent Program? Navigating Training and Credentialing Issues in a Competitive Landscape

Monday, February 09, 2026
3:34 PM - 3:45 PM

Focused Symposium: Carotid Stenting Today: Starting from Scratch

Monday, February 09, 2026
4:00 PM - 6:00 PM

Session 5: Developing a Carotid Program in Today’s Environment

Wednesday, February 11, 2026
3:20 PM - 4:10 PM

Current Technologies for Carotid Stents

Wednesday, February 11, 2026
3:27 PM - 3:34 PM

Discussion: The Role of Carotid Stenting in the Current Environment, The Value of A Carotid Program

Wednesday, February 11, 2026
3:55 PM - 4:10 PM
Back to top